High-Intensity Interval Training for Sarcopenia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how high-intensity interval training (HIIT) can improve muscle health in individuals with sarcopenia, a condition where muscles weaken and shrink with age. Over nine weeks, participants will attend HIIT classes at a community gym twice a week. The researchers aim to determine if these workouts can enhance heart health, balance, strength, and muscle quality. Individuals who can walk 100 feet without assistance and have no serious mental challenges or exercise restrictions may find this trial suitable. As an unphased trial, this study offers a unique opportunity to contribute to understanding the benefits of exercise on muscle health in aging.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this high-intensity interval training is safe for sarcopenia?
Research has shown that High-Intensity Interval Training (HIIT) is generally safe for most people, including older adults. Studies have found that HIIT strengthens muscles and improves overall health. In terms of safety, HIIT is well-tolerated, meaning most people can engage in it without major issues.
One study focused on older adults found that HIIT improved heart and muscle health, suggesting it can help with conditions like sarcopenia, which involves muscle loss. While HIIT can be intense, starting at a comfortable level and gradually increasing the effort is important.
Overall, HIIT is a safe and effective way to enhance muscle and heart health. Consulting a healthcare provider before starting any new exercise program is always advisable.12345Why are researchers excited about this trial?
High-Intensity Interval Training (HIIT) is unique because it offers a non-pharmaceutical approach to combating sarcopenia. Unlike traditional treatments, which might involve resistance training or supplements like protein and amino acids, HIIT focuses on short bursts of intense exercise followed by rest. This method is thought to efficiently stimulate muscle growth and improve physical function in a way that traditional steady-state exercises might not. Researchers are excited because HIIT could provide a time-efficient, accessible, and potentially more engaging alternative to improve muscle health for those dealing with age-related muscle loss.
What evidence suggests that high-intensity interval training is effective for sarcopenia?
Research has shown that high-intensity interval training (HIIT), which participants in this trial will undergo, can help treat sarcopenia, a condition where muscles weaken and shrink with age. In one study, 75% of people with sarcopenia improved after doing HIIT. Another study found that HIIT not only boosts muscle strength but also helps prevent muscle loss. These workouts involve short bursts of intense exercise followed by rest, improving muscle function and physical performance more than moderate exercise. Overall, HIIT offers a promising approach to addressing muscle loss and weakness.12346
Are You a Good Fit for This Trial?
This trial is for individuals with sarcopenia, which is the loss of muscle mass and strength that happens with age. Participants should be interested in attending a high-intensity interval training (HIIT) class twice a week at a community gym for 9 weeks.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 9-week high-intensity interval training (HIIT) class using functional movements within a community-based gym, twice a week.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- High-Intensity Interval Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Creighton University
Lead Sponsor